Published in J Atheroscler Thromb on January 01, 2005
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab (2008) 7.97
Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res (2010) 2.49
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
A comprehensive definition for metabolic syndrome. Dis Model Mech (2009) 2.23
eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab (2009) 2.04
A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr (2010) 1.86
Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol (2012) 1.75
Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38
Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol (2009) 1.36
Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol (2013) 1.35
Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health (2010) 1.27
Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study. Psychosom Med (2008) 1.27
Fat: a matter of disturbance for the immune system. World J Gastroenterol (2010) 1.13
Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care (2012) 1.12
Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study. BMC Public Health (2011) 1.11
Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism (2007) 1.08
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res (2006) 1.03
Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res (2012) 1.03
Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women. PLoS One (2013) 1.03
PPAR-gamma in the Cardiovascular System. PPAR Res (2008) 1.01
Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol (2009) 0.99
Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region. Middle East Afr J Ophthalmol (2012) 0.99
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone. Circulation (2011) 0.97
Neprilysin, obesity and the metabolic syndrome. Int J Obes (Lond) (2010) 0.96
APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J Nutr (2011) 0.96
Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS One (2014) 0.95
Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J Diabetes (2010) 0.95
Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study. Cardiovasc Diabetol (2012) 0.93
Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One (2013) 0.92
Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol (2009) 0.92
2008 Landis Award lecture. Inflammation and the autodigestion hypothesis. Microcirculation (2009) 0.91
Silent ischemic heart disease and pericardial fat volume in HIV-infected patients: a case-control myocardial perfusion scintigraphy study. PLoS One (2013) 0.90
Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target. Vasc Health Risk Manag (2008) 0.90
Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? Nutr Metab (Lond) (2009) 0.87
Influence of change in aerobic fitness and weight on prevalence of metabolic syndrome. Prev Chronic Dis (2012) 0.87
MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort. Vasc Health Risk Manag (2010) 0.87
Link of dietary patterns with metabolic syndrome: analysis of the National Health and Nutrition Examination Survey. Nutr Diabetes (2017) 0.86
Time-of-day and nutrient composition of eating occasions: prospective association with the metabolic syndrome in the 1946 British birth cohort. Int J Obes (Lond) (2012) 0.85
Abdominal obesity and the metabolic syndrome: a surgeon's perspective. Can J Cardiol (2008) 0.85
Alcohol use behaviors and risk of metabolic syndrome in South Korean middle-aged men. BMC Public Health (2011) 0.85
Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging (2015) 0.84
Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol Cancer (2009) 0.84
Network-based integration of molecular and physiological data elucidates regulatory mechanisms underlying adaptation to high-fat diet. Genes Nutr (2015) 0.83
Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr (2016) 0.83
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells Int (2011) 0.83
Extracts of pomelo peels prevent high-fat diet-induced metabolic disorders in c57bl/6 mice through activating the PPARα and GLUT4 pathway. PLoS One (2013) 0.83
Upregulation of GAD65 mRNA in the medulla of the rat model of metabolic syndrome. Neurosci Lett (2007) 0.82
Metabolic syndrome in peritoneal dialysis patients. NDT Plus (2008) 0.82
REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American. Mol Nutr Food Res (2013) 0.82
Prevalence of metabolic syndrome in mainland china: a meta-analysis of published studies. BMC Public Health (2016) 0.82
Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score. Mol Clin Oncol (2013) 0.81
Predictors of metabolic syndrome in participants of a cardiac rehabilitation program. ISRN Cardiol (2012) 0.81
Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease. Hum Genet (2008) 0.81
Associations between Dietary Antioxidant Intake and Metabolic Syndrome. PLoS One (2015) 0.81
Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment. Diabetes (2009) 0.80
Adolescent metabolic syndrome risk is increased with higher infancy weight gain and decreased with longer breast feeding. Int J Pediatr (2012) 0.80
Gender differences in the effect of obesity on chronic diseases among the elderly Koreans. J Korean Med Sci (2011) 0.79
Waist-to-Height Ratio as an Index for Cardiometabolic Risk in Adolescents: Results from the 1998-2008 KNHANES. Yonsei Med J (2016) 0.79
Serum heat shock protein 27 antigen and antibody levels appear to be related to the macrovascular complications associated with insulin resistance: a pilot study. Cell Stress Chaperones (2009) 0.79
Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling. Arterioscler Thromb Vasc Biol (2013) 0.79
Utility of Heart-type Fatty Acid Binding Protein as a New Biochemical Marker for the Early Diagnosis of Acute Coronary Syndrome. J Clin Diagn Res (2015) 0.79
Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation. J Biol Chem (2015) 0.79
Different impacts of metabolic syndrome components on insulin resistance in type 2 diabetes. Int J Endocrinol (2013) 0.78
Recommended Levels of Physical Activity Are Associated with Reduced Risk of the Metabolic Syndrome in Mexican-Americans. PLoS One (2016) 0.78
Cardiometabolic risk among African American women: a pilot study. J Cardiovasc Nurs (2009) 0.78
Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome. J Diabetes Investig (2014) 0.78
EFFECT OF SIZE OF INTESTINAL DIVERSIONS IN OBESE PATIENTS WITH METABOLIC SYNDROME SUBMITTED TO GASTRIC BYPASS. Arq Bras Cir Dig (2016) 0.78
Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and Women. PLoS One (2015) 0.77
Metabolic syndrome among obese Qataris attending primary health care centers in Doha, 2010. J Family Community Med (2012) 0.77
Number of components of the metabolic syndrome; smoking and inflammatory markers. Int J Endocrinol Metab (2012) 0.77
Comparison of vegetarian diets and omnivorous diets on plasma level of HDL-c: a meta-analysis. PLoS One (2014) 0.77
Diet, physical activity and socio-economic disparities of obesity in Lebanese adults: findings from a national study. BMC Public Health (2015) 0.77
Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project. J Womens Health (Larchmt) (2014) 0.77
People United to Sustain Health (PUSH): a community-based participatory research study. Clin Transl Sci (2014) 0.76
Aging attenuates the association of central obesity with the accumulation of metabolic risk factors when assessed using the waist circumference measured at the umbilical level (the Japanese standard method). Nutr Diabetes (2013) 0.76
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci (2017) 0.76
Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar. BMJ Open Diabetes Res Care (2016) 0.75
Relationship between epicardial adipose tissue thickness and vitamin D in patients with metabolic syndrome. Int J Clin Exp Med (2015) 0.75
Waist-to-height ratio is an effective indicator for comprehensive cardiovascular health. Sci Rep (2017) 0.75
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. J Clin Res Pediatr Endocrinol (2016) 0.75
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep (2016) 0.75
Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model. BMC Public Health (2014) 0.75
A Lebanese dietary pattern promotes better diet quality among older adults: findings from a national cross-sectional study. BMC Geriatr (2016) 0.75
Adding diet and exercise counseling to the health promotion plan alleviates anthropometric and metabolic complications in patients with metabolic syndrome. Nutr Metab Insights (2012) 0.75
Relationship between body weight and the increment in serum brain-derived neurotrophic factor after oral glucose challenge in men with obesity and metabolic syndrome: A prospective study. Medicine (Baltimore) (2016) 0.75
Prevalence and risk factors of retinopathy in patients with or without metabolic syndrome: a population-based study in Shenyang. BMJ Open (2015) 0.75
Therapeutic Depletion of Iron Stores Is Not Associated with a Reduced Hemoglobin Mass in a Hemochromatosis Patient. Case Rep Gastroenterol (2016) 0.75
Prevalence of Metabolic Syndrome and Its Clinical and Angiographic Profile in Patients With Naive Acute Coronary Syndrome in North Indian Population. J Clin Med Res (2016) 0.75
Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. BMJ Open (2016) 0.75
A Cross-Sectional Study of the Prevalence of Metabolic Syndrome and Associated Factors in Colombian Collegiate Students: The FUPRECOL-Adults Study. Int J Environ Res Public Health (2017) 0.75
Influence of Helicobacter pylori Infection on Metabolic Syndrome in Old Chinese People. Gastroenterol Res Pract (2016) 0.75
Prevalence of Metabolic Syndrome and Its Components among Japanese Workers by Clustered Business Category. PLoS One (2016) 0.75
Neck circumference might predict gestational diabetes mellitus in Han Chinese women: A nested case-control study. J Diabetes Investig (2016) 0.75
Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study. Lipids Health Dis (2016) 0.75
Study of the relationship between male erectile dysfunction and type 2 diabetes mellitus/metabolic syndrome and its components. J Int Med Res (2016) 0.75
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract (2011) 15.13
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Retracted Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (2004) 7.21
The metabolic syndrome in children and adolescents. Lancet (2007) 5.97
Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract (2010) 5.16
Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol (2003) 4.86
The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes (2007) 4.84
Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol (2003) 3.89
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2002) 3.81
Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation (2003) 3.73
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Genome sequence of Aeromonas hydrophila ATCC 7966T: jack of all trades. J Bacteriol (2006) 3.33
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes (2003) 3.28
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates. Diabetes Res Clin Pract (2002) 3.18
Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res (2004) 3.16
Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem (2002) 3.05
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A (2004) 2.85
High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care (2002) 2.73
Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension (2004) 2.65
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation (2004) 2.58
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology (2003) 2.53
Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol (2010) 2.50
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes (2002) 2.49
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation (2002) 2.40
Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res (2003) 2.35
Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension (2003) 2.32
Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) (2006) 2.31
Adiponectin as a biomarker of the metabolic syndrome. Circ J (2004) 2.22
Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension (2012) 2.17
Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J (2010) 2.13
Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care (2004) 2.13
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care (2003) 2.05
Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet (2008) 2.03
Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J (2009) 2.01
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev (2010) 1.97
c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors. J Gastroenterol Hepatol (2003) 1.84
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc Res (2005) 1.84
Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J (2008) 1.81
Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes (2008) 1.78
Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab (2002) 1.78
The cost of overweight and obesity in Australia. Med J Aust (2010) 1.77
Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab (2003) 1.75
The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab (2005) 1.72
Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) (2005) 1.70
A comparison of blood glucose meters in Australia. Diabetes Res Clin Pract (2005) 1.66
A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care (2005) 1.66
Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol (2005) 1.64
Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes (2002) 1.63
Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res (2005) 1.61
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60
Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care (2006) 1.56
Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens (2003) 1.55
Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1. J Gastroenterol (2002) 1.54
Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med (2009) 1.54
CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass. J Atheroscler Thromb (2015) 1.50
Socioeconomic position, gender, health behaviours and biomarkers of cardiovascular disease and diabetes. Soc Sci Med (2010) 1.50
Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb (2006) 1.50
Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow up. Intern Med (2010) 1.48
Retraction. Science (2007) 1.48
High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort- and sex-matched blood donors in a Japanese population. Hepatology (2002) 1.48
Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J Hepatol (2004) 1.45
Gestational diabetes and hypertensive disorders of pregnancy among women veterans deployed in service of operations in Afghanistan and Iraq. J Womens Health (Larchmt) (2014) 1.44
Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med (2002) 1.44
Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis. Dig Dis Sci (2011) 1.43
A decreased number of c- kit-expressing cells in a patient with afferent loop syndrome. J Gastroenterol (2003) 1.41
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2008) 1.37
Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab (2008) 1.37
Plasma lipid profiling in a large population-based cohort. J Lipid Res (2013) 1.35
Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes. Diabetes Care (2005) 1.35
Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab (2004) 1.34
Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care (2002) 1.34
Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes (2002) 1.33
Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr (2005) 1.32
Available carbon source influences the resistance of Neisseria meningitidis against complement. J Exp Med (2005) 1.30
Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke (2008) 1.29
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS (2003) 1.29
Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care (2008) 1.29
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2009) 1.28
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation (2011) 1.27
Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol (2004) 1.26
Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes (2007) 1.26
Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab (2002) 1.26
Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med (2003) 1.25
Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One (2013) 1.24
Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci U S A (2004) 1.23
Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J (2002) 1.23
Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. Diabetes (2005) 1.21
Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie (2012) 1.21
Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care (2007) 1.20
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol (2002) 1.20